AT1 receptor in rostral ventrolateral medulla mediating blunted baroreceptor reflex in spontaneously hypertensive rats

Xin Ya Gao, Feng Zhang, Ying Han, Han Jun Wang, Ying Zhang, Rui Guo, Guo Qing Zhu

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

AIM: To determine the role of AT1 receptor in the rostral ventrolateral medulla (RVLM) in mediating the blunted baroreceptor reflex in spontaneously hypertensive rats (SHR). METHODS: Intravenous injections of graded doses of phenylephrine (1, 5, 10, 20, and 40 μg/kg) increased the blood pressure to elicit the baroreceptor reflex in both SHR and normotensive Wistar rats anesthetized with urethane. The baroreceptor reflex sensitivity (BRS) was determined before and after microinjection of Ang II, losartan, or AT 1 receptor antisense oligodeoxynucleotides into the RVLM. AT 1 receptor protein level in the RVLM was measured by Western blotting. RESULTS: The BRS was significantly decreased in SHR compared with normal rats. Bilateral microinjection of AT1 receptor antagonist losartan (250 nmol/h) into the RVLM partly reversed the blunted BRS in SHR, but had no significant effect on the BRS in normal rats. Ang II (1.5 nmol/h) significantly inhibited the BRS in normal rats, which was completely abolished by pretreatment with losartan. However, no significant change in the BRS was observed after microinjection of Ang II into the RVLM in SHR. Bilateral microinjection of AT1 receptor antisense oligodeoxynucleotides (ASODN) into the RVLM partially recovered the blunted BRS in SHR after 3 h, but no significant change in the BRS was observed in normal rats. The AT1 receptor protein level significantly decreased after administration of ASODN. CONCLUSION: Blockage of AT1 receptor or inhibition of AT1 receptor protein synthesis in the RVLM enhanced the BRS in SHR, suggesting that the enhanced activities of AT1 receptor in the RVLM contribute to the blunted BRS in SHR.

Original languageEnglish (US)
Pages (from-to)1433-1438
Number of pages6
JournalActa Pharmacologica Sinica
Volume25
Issue number11
StatePublished - Nov 1 2004

Fingerprint

Baroreflex
Inbred SHR Rats
Rats
Microinjections
Losartan
Oligodeoxyribonucleotides
Proteins
Urethane
Phenylephrine
Blood pressure
Intravenous Injections
Wistar Rats
Western Blotting

Keywords

  • Angiotensin II
  • Antisense oligodeoxynucleotide
  • Baroreceptor reflex
  • Hypertension
  • Rostral ventrolateral medulla

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

AT1 receptor in rostral ventrolateral medulla mediating blunted baroreceptor reflex in spontaneously hypertensive rats. / Gao, Xin Ya; Zhang, Feng; Han, Ying; Wang, Han Jun; Zhang, Ying; Guo, Rui; Zhu, Guo Qing.

In: Acta Pharmacologica Sinica, Vol. 25, No. 11, 01.11.2004, p. 1433-1438.

Research output: Contribution to journalArticle

Gao, Xin Ya ; Zhang, Feng ; Han, Ying ; Wang, Han Jun ; Zhang, Ying ; Guo, Rui ; Zhu, Guo Qing. / AT1 receptor in rostral ventrolateral medulla mediating blunted baroreceptor reflex in spontaneously hypertensive rats. In: Acta Pharmacologica Sinica. 2004 ; Vol. 25, No. 11. pp. 1433-1438.
@article{f76203f2f47c4060983934064be4c2f9,
title = "AT1 receptor in rostral ventrolateral medulla mediating blunted baroreceptor reflex in spontaneously hypertensive rats",
abstract = "AIM: To determine the role of AT1 receptor in the rostral ventrolateral medulla (RVLM) in mediating the blunted baroreceptor reflex in spontaneously hypertensive rats (SHR). METHODS: Intravenous injections of graded doses of phenylephrine (1, 5, 10, 20, and 40 μg/kg) increased the blood pressure to elicit the baroreceptor reflex in both SHR and normotensive Wistar rats anesthetized with urethane. The baroreceptor reflex sensitivity (BRS) was determined before and after microinjection of Ang II, losartan, or AT 1 receptor antisense oligodeoxynucleotides into the RVLM. AT 1 receptor protein level in the RVLM was measured by Western blotting. RESULTS: The BRS was significantly decreased in SHR compared with normal rats. Bilateral microinjection of AT1 receptor antagonist losartan (250 nmol/h) into the RVLM partly reversed the blunted BRS in SHR, but had no significant effect on the BRS in normal rats. Ang II (1.5 nmol/h) significantly inhibited the BRS in normal rats, which was completely abolished by pretreatment with losartan. However, no significant change in the BRS was observed after microinjection of Ang II into the RVLM in SHR. Bilateral microinjection of AT1 receptor antisense oligodeoxynucleotides (ASODN) into the RVLM partially recovered the blunted BRS in SHR after 3 h, but no significant change in the BRS was observed in normal rats. The AT1 receptor protein level significantly decreased after administration of ASODN. CONCLUSION: Blockage of AT1 receptor or inhibition of AT1 receptor protein synthesis in the RVLM enhanced the BRS in SHR, suggesting that the enhanced activities of AT1 receptor in the RVLM contribute to the blunted BRS in SHR.",
keywords = "Angiotensin II, Antisense oligodeoxynucleotide, Baroreceptor reflex, Hypertension, Rostral ventrolateral medulla",
author = "Gao, {Xin Ya} and Feng Zhang and Ying Han and Wang, {Han Jun} and Ying Zhang and Rui Guo and Zhu, {Guo Qing}",
year = "2004",
month = "11",
day = "1",
language = "English (US)",
volume = "25",
pages = "1433--1438",
journal = "Zhongguo yao li xue bao = Acta pharmacologica Sinica",
issn = "1671-4083",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - AT1 receptor in rostral ventrolateral medulla mediating blunted baroreceptor reflex in spontaneously hypertensive rats

AU - Gao, Xin Ya

AU - Zhang, Feng

AU - Han, Ying

AU - Wang, Han Jun

AU - Zhang, Ying

AU - Guo, Rui

AU - Zhu, Guo Qing

PY - 2004/11/1

Y1 - 2004/11/1

N2 - AIM: To determine the role of AT1 receptor in the rostral ventrolateral medulla (RVLM) in mediating the blunted baroreceptor reflex in spontaneously hypertensive rats (SHR). METHODS: Intravenous injections of graded doses of phenylephrine (1, 5, 10, 20, and 40 μg/kg) increased the blood pressure to elicit the baroreceptor reflex in both SHR and normotensive Wistar rats anesthetized with urethane. The baroreceptor reflex sensitivity (BRS) was determined before and after microinjection of Ang II, losartan, or AT 1 receptor antisense oligodeoxynucleotides into the RVLM. AT 1 receptor protein level in the RVLM was measured by Western blotting. RESULTS: The BRS was significantly decreased in SHR compared with normal rats. Bilateral microinjection of AT1 receptor antagonist losartan (250 nmol/h) into the RVLM partly reversed the blunted BRS in SHR, but had no significant effect on the BRS in normal rats. Ang II (1.5 nmol/h) significantly inhibited the BRS in normal rats, which was completely abolished by pretreatment with losartan. However, no significant change in the BRS was observed after microinjection of Ang II into the RVLM in SHR. Bilateral microinjection of AT1 receptor antisense oligodeoxynucleotides (ASODN) into the RVLM partially recovered the blunted BRS in SHR after 3 h, but no significant change in the BRS was observed in normal rats. The AT1 receptor protein level significantly decreased after administration of ASODN. CONCLUSION: Blockage of AT1 receptor or inhibition of AT1 receptor protein synthesis in the RVLM enhanced the BRS in SHR, suggesting that the enhanced activities of AT1 receptor in the RVLM contribute to the blunted BRS in SHR.

AB - AIM: To determine the role of AT1 receptor in the rostral ventrolateral medulla (RVLM) in mediating the blunted baroreceptor reflex in spontaneously hypertensive rats (SHR). METHODS: Intravenous injections of graded doses of phenylephrine (1, 5, 10, 20, and 40 μg/kg) increased the blood pressure to elicit the baroreceptor reflex in both SHR and normotensive Wistar rats anesthetized with urethane. The baroreceptor reflex sensitivity (BRS) was determined before and after microinjection of Ang II, losartan, or AT 1 receptor antisense oligodeoxynucleotides into the RVLM. AT 1 receptor protein level in the RVLM was measured by Western blotting. RESULTS: The BRS was significantly decreased in SHR compared with normal rats. Bilateral microinjection of AT1 receptor antagonist losartan (250 nmol/h) into the RVLM partly reversed the blunted BRS in SHR, but had no significant effect on the BRS in normal rats. Ang II (1.5 nmol/h) significantly inhibited the BRS in normal rats, which was completely abolished by pretreatment with losartan. However, no significant change in the BRS was observed after microinjection of Ang II into the RVLM in SHR. Bilateral microinjection of AT1 receptor antisense oligodeoxynucleotides (ASODN) into the RVLM partially recovered the blunted BRS in SHR after 3 h, but no significant change in the BRS was observed in normal rats. The AT1 receptor protein level significantly decreased after administration of ASODN. CONCLUSION: Blockage of AT1 receptor or inhibition of AT1 receptor protein synthesis in the RVLM enhanced the BRS in SHR, suggesting that the enhanced activities of AT1 receptor in the RVLM contribute to the blunted BRS in SHR.

KW - Angiotensin II

KW - Antisense oligodeoxynucleotide

KW - Baroreceptor reflex

KW - Hypertension

KW - Rostral ventrolateral medulla

UR - http://www.scopus.com/inward/record.url?scp=8544273684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8544273684&partnerID=8YFLogxK

M3 - Article

C2 - 15525464

AN - SCOPUS:8544273684

VL - 25

SP - 1433

EP - 1438

JO - Zhongguo yao li xue bao = Acta pharmacologica Sinica

JF - Zhongguo yao li xue bao = Acta pharmacologica Sinica

SN - 1671-4083

IS - 11

ER -